Using CRISPR-Cas9 mediated gene editing, the team of scientists created individual cell lines in which specific blood group genes were altered to prevent the expression of blood group proteins that can cause immune reactions.
Scientists have developed a potentially breakthrough CRISPR gene-editing tool. It could allow researchers to take fragments of DNA extracted from human cells, put them into a test tube, and quickly and precisely engineer multiple changes to the genetic code.
Using a Raman microscope, researchers have studied at which targets the cancer drug Neratinib binds in cells and how its chemical structure changes. Compared with other techniques, this method offers a considerable advantage, as it is not necessary to apply a label to the drug that would indicate its distribution indirectly; rather, the drug itself can be monitored.